Congo, The Democratic Republic of the
News Category
NanoViricides Seeks DRC Approval for Phase II Ebola Trial of Oral Antiviral NV-387
NanoViricides has applied to the Democratic Republic of Congo's regulatory agency to begin a Phase II clinical trial of its oral antiviral NV-387 for ...
NanoViricides Receives Ethics Approval for Phase II Ebola Trial in DRC
NanoViricides has received National Ethics Committee approval in the DRC for a Phase II trial of its oral NV-387 gummies against Bundibugyo ebolavirus...
Congo’s Copper and Cobalt Production Unscathed by Middle East Unrest
The Democratic Republic of Congo's mining ministry reports that copper and cobalt production remains unaffected by Middle East disruptions, offering s...
NanoViricides Advances Oral Ebola Treatment NV-387 Toward Phase II Trial in DRC
NanoViricides reports progress on NV-387, a broad-spectrum oral antiviral candidate for Bundibugyo ebolavirus, with Phase II trial approval pending in...
NanoViricides Ships NV-387 Drug Supply to DRC for Phase II MPox Trial
NanoViricides has shipped NV-387 Oral Gummies to the Democratic Republic of Congo for a Phase II trial against MPox, with potential implications for t...